Facioscapulohumeral muscular dystrophy 3 is a rare inherited muscle condition that usually causes slowly worsening weakness in the face, shoulders, and upper arms. Early symptoms of Facioscapulohumeral muscular dystrophy 3 can include trouble smiling, whistling, lifting the arms, or keeping the shoulder blades flat against the back. It often starts in the teens or adulthood, but the age it begins and the severity can vary within families. Not everyone will have the same experience. Facioscapulohumeral muscular dystrophy 3 is usually lifelong, and treatment focuses on physical therapy, exercise guidance, pain support, and sometimes braces or surgery, while life expectancy is often near usual but can be affected in more severe cases.
How many people live with Facioscapulohumeral muscular dystrophy 3?
The broader condition, facioscapulohumeral muscular dystrophy, is estimated to affect about 320,000 to 960,000 people worldwide (NINDS, 2024) and about 13,000 to 40,000 people in the United States (NINDS, 2024), with the range reflecting differences in how cases are diagnosed and counted. Facioscapulohumeral muscular dystrophy 3 is a much rarer form, but rare disease sources such as Orphanet do not give a separate worldwide or U.S. count for it, so no reliable numeric estimate is available for this type alone (Orphanet, 2024).
Overview
Facioscapulohumeral muscular dystrophy 3Symptoms
Facioscapulohumeral muscular dystrophy 3 often causes slowly worsening weakness in the face, shoulders, and upper arms. Early symptoms of facioscapulohumeral muscular dystrophy 3 can include trouble smiling, whistling, lifting objects, or raising the arms. Some people also develop leg weakness.
Outlook and prognosis
Facioscapulohumeral muscular dystrophy 3 often progresses slowly, and many people stay mobile and independent for years. Weakness can gradually affect lifting, walking, or facial movement, but life expectancy is usually normal and symptoms vary widely.
Causes and risk factors
Facioscapulohumeral muscular dystrophy 3 is caused by a change in the SMCHD1 gene, usually inherited in families but sometimes new. Risk is genetic, while lifestyle or environmental factors do not cause it, though overall health can affect severity and complications.
Genetic influences
Genetics are central to facioscapulohumeral muscular dystrophy 3. It is caused by changes affecting how the DUX4 gene is switched on, and these genetic differences can help confirm the diagnosis and explain why symptoms vary between families.
Diagnosis
Facioscapulohumeral muscular dystrophy 3 is diagnosed from clinical features, such as a typical pattern of muscle weakness, along with a family history. Genetic tests help confirm the diagnosis of facioscapulohumeral muscular dystrophy 3.
Treatment and drugs
Treatment for Facioscapulohumeral muscular dystrophy 3 focuses on keeping muscles working as well as possible. Physical therapy, gentle exercise, braces, pain relief, and care for shoulder weakness, breathing, hearing, or eye problems can all help.
Symptoms
Facioscapulohumeral muscular dystrophy 3, often shortened to FSHD3, usually affects muscles of the face, shoulders, and upper arms first, but other muscle groups can be involved too. In daily life, this can mean trouble whistling, lifting items onto a shelf, or keeping the shoulders steady when reaching overhead. The early features of facioscapulohumeral muscular dystrophy 3 can be easy to miss at first, and features vary from person to person and can change over time.
Weakness in the face can make it hard to smile fully, whistle, puff out the cheeks, or close the eyes tightly. Some people notice food or drink slipping from the lips, and the eyes may feel dry or irritated if the eyelids do not shut well.
Muscles around the shoulders often weaken, so washing hair, reaching into a high cabinet, or lifting bags overhead becomes harder. The shoulder blades may stick out from the back, which many people notice in a mirror or when putting on a shirt.
Weakness in the upper arms can make pulling, pushing, and lifting feel harder than expected. Everyday tasks like fastening a seat belt, carrying groceries, or placing a box on a shelf may take more effort.
Weakness in the belly and back muscles can affect posture and make it harder to sit up from lying down or keep the trunk steady. Some people with FSHD3 develop a more pronounced lower back curve or feel less stable when standing for long periods.
How people usually first notice Facioscapulohumeral muscular dystrophy 3?
How facioscapulohumeral muscular dystrophy 3 is first noticed can vary, but many people first see subtle weakness in the face, shoulders, or upper arms, such as trouble whistling, fully closing the eyes during sleep, lifting the arms overhead, or shoulder blades that stick out like wings. In some families, the first signs of facioscapulohumeral muscular dystrophy 3 show up in childhood, while in others they are not clear until the teen years or adulthood, when exercise, sports, or everyday tasks start to feel harder than expected. Doctors may first recognize it when they notice this pattern of muscle weakness, especially if it slowly progresses and other relatives have had similar symptoms.
Types of Facioscapulohumeral muscular dystrophy 3
No distinct types of Facioscapulohumeral muscular dystrophy 3 are widely recognized.
Can I slow down the onset of symptoms?
At this time, there is no proven way to reliably slow or prevent the start of symptoms in facioscapulohumeral muscular dystrophy 3, because it is an inherited muscle condition. Research is still ongoing, and while general healthy habits like staying active, sleeping well, and not smoking may support overall muscle and body health, they have not been clearly shown to delay when symptoms begin. There is no established preventive medicine, but regular follow-up with a doctor who knows muscle diseases can help spot problems early and support day-to-day function, which is still worthwhile even if it may not change the age symptoms start.
What genetics can tell you about symptoms
In facioscapulohumeral muscular dystrophy 3, genetics can explain part of why symptoms vary, but it usually cannot predict the exact course for one person. Changes in genes that affect how certain DNA regions are switched on and off can influence which muscles become weak, how early symptoms start, and how severe they are, yet even people in the same family may be affected very differently. For many living with this condition, genetics offers clues about risk and typical patterns, but it does not provide a precise forecast of day-to-day symptoms.
Causes and risk factors
In facioscapulohumeral muscular dystrophy 3, the main cause is a change in the LRIF1 gene. This gene change weakens the normal block on a harmful gene called DUX4, so muscle cells are more likely to be damaged. The change may be inherited from a parent, but it can also happen for the first time in one person. Risk can vary widely from person to person. Age, sex, activity level, smoke exposure, and overall health may affect when early symptoms of facioscapulohumeral muscular dystrophy 3 start and how severe they become, but they are not the root cause.
What are the most common causes or risk factors?
Facioscapulohumeral muscular dystrophy 3 is mainly caused by an inherited change in a gene called LRIF1, together with a certain DNA pattern on chromosome 4 that allows a normally silent muscle-damaging gene to switch on. The biggest risk factor is having a parent or other close family member with the condition, although the gene change can sometimes happen for the first time in someone with no family history. There are no well-proven lifestyle or environmental causes, so it is not known to be triggered by diet, exercise, or an injury.
Environmental and biological risk factors
For facioscapulohumeral muscular dystrophy 3, experts have not identified clear environmental or non-genetic biological risk factors that reliably raise the chance of the condition occurring. Researchers are still exploring how outside influences interact with our inner biology. At this point, there is no well-established evidence that common exposures during pregnancy, birth, or later life cause facioscapulohumeral muscular dystrophy 3.
Genetic risk factors
Facioscapulohumeral muscular dystrophy 3 is rare and usually happens when more than one inherited change comes together. The best-known pattern involves a change in DNMT3B plus a specific chromosome 4 background that allows the DUX4 gene to stay switched on in muscle. Carrying a genetic change doesn’t guarantee the condition will appear.
DNMT3B variants: Facioscapulohumeral muscular dystrophy 3 is most strongly linked to changes in DNMT3B, a gene that helps keep certain stretches of DNA under tight control. When that control is weakened, muscle cells can wrongly allow DUX4 activity.
4qA chromosome: Most people with facioscapulohumeral muscular dystrophy 3 also have a specific version of chromosome 4 called 4qA. This version provides the signal that lets the DUX4 message persist, which is a key step in disease.
Two genetic hits: In facioscapulohumeral muscular dystrophy 3, a DNMT3B change alone is often not enough to cause symptoms. Risk is higher when it is paired with the permissive 4qA background, which is why genetic testing for facioscapulohumeral muscular dystrophy 3 usually looks for both pieces.
Family history: The genetic factors behind facioscapulohumeral muscular dystrophy 3 can be passed down in families. In some families, one side may carry the DNMT3B change and the other may carry the 4qA background, so the inheritance pattern can look less straightforward than a single-gene condition.
New variants: Some people develop facioscapulohumeral muscular dystrophy 3 because a new DNMT3B change arises for the first time in them. Even in those cases, the chromosome 4 background still plays an important role.
Lifestyle risk factors
Facioscapulohumeral muscular dystrophy 3 is an inherited muscle disorder, so lifestyle habits do not cause it. However, how lifestyle affects facioscapulohumeral muscular dystrophy 3 can be important for fatigue, pain, mobility, breathing, and long-term complications. The most helpful focus is on habits that support muscle function and reduce avoidable strain on already weakened muscle groups.
Too little activity can speed deconditioning, while excessive or high-intensity exercise can worsen pain, fatigue, and muscle overuse in facioscapulohumeral muscular dystrophy 3. Individually tailored, low-impact exercise and guided strengthening may help maintain mobility and endurance without adding unnecessary muscle damage.
Repeated pushing through marked fatigue can make daily weakness feel worse and may prolong recovery after activity in people with facioscapulohumeral muscular dystrophy 3. Pacing, planned rest, and energy conservation can help preserve function across the day.
Excess body weight increases the load on weak shoulder, trunk, hip, and leg muscles, which can worsen gait problems, balance issues, and fatigue. Maintaining a healthy weight may reduce stress on muscles and joints and make transfers and walking easier.
Poor nutrition can contribute to low energy, unwanted weight gain, and loss of muscle support, even though diet does not cause the condition itself. A balanced diet with adequate protein, fiber, and micronutrients may help support strength, bone health, and overall function.
Risk prevention
Facioscapulohumeral muscular dystrophy 3 cannot usually be prevented because it is a genetic condition. In everyday life, prevention focuses on lowering the risk of complications, slowing avoidable decline, and protecting independence for as long as possible. Prevention is about lowering risk, not eliminating it completely. For many living with facioscapulohumeral muscular dystrophy 3, that means regular follow-up, tailored activity, and early support when new symptoms appear.
Ongoing care with a neurologist or rehabilitation team can catch changes early and help adjust treatment. This can lower the risk of falls, worsening weakness, and avoidable loss of function.
Gentle, regular activity and physical therapy can help keep muscles working, joints moving, and daily tasks easier. Exercise should be matched to your strength level, since overexertion can sometimes make symptoms worse.
Stretching, posture work, and braces or supports when needed may help prevent contractures and painful stiffness. Many people with facioscapulohumeral muscular dystrophy 3 find that small changes, like better shoulder support or ankle bracing, make walking and reaching safer.
Weakness in the hips, legs, or core can make stairs, uneven ground, or getting up from a chair harder. Safe footwear, home adjustments, and balance training can reduce the chance of falls and injuries.
Can you prevent Facioscapulohumeral muscular dystrophy 3?
No, facioscapulohumeral muscular dystrophy 3 cannot usually be prevented because it is caused by a change in genes, not by lifestyle or anything a person did. Healthy habits can support general well-being, but they do not stop this condition from developing. If it runs in your family, genetic counseling can help you understand the chances of passing it on and talk through family-planning options.
Transmission
Facioscapulohumeral muscular dystrophy 3 is not infectious, so it cannot spread from one person to another through touch, kissing, coughing, sex, blood, food, or sharing a home. Instead, how facioscapulohumeral muscular dystrophy 3 is inherited is a genetics question: it can run in families when a parent passes on the underlying genetic change, and in some cases it starts for the first time in one family member. For many living with facioscapulohumeral muscular dystrophy 3, inheritance is more complex than a simple one-gene pattern because the condition may depend on more than one genetic factor working together. That is why relatives can have different risks and different symptom severity, even within the same family.
When to test your genes
Consider genetic testing if you have unexplained facial, shoulder, or upper arm weakness, or a family history of facioscapulohumeral muscular dystrophy. Testing can confirm the diagnosis, clarify recurrence risk for relatives and future children, and help tailor follow-up such as strength, breathing, hearing, and eye monitoring.
Diagnosis
Facioscapulohumeral muscular dystrophy 3 is usually diagnosed when a pattern of muscle weakness raises concern, often around the face, shoulders, and upper arms. A doctor puts together the story from symptoms, the exam, and test results rather than relying on just one finding. Getting a diagnosis is often a turning point toward answers and support. Because several muscle conditions can look similar at first, the diagnosis of facioscapulohumeral muscular dystrophy 3 may take more than one step.
Doctors ask about when weakness started, which muscles were affected first, and whether symptoms have changed over time. A detailed family and health history can help spot a pattern that suggests an inherited muscle condition.
The exam looks for the typical pattern of weakness in the face, shoulder blades, upper arms, and sometimes the lower legs. Doctors also check posture, walking, arm lifting, and whether the shoulder blades stick out more than usual.
A blood test may check creatine kinase, a marker that can rise when muscles are damaged. Levels in facioscapulohumeral muscular dystrophy 3 are often normal or only mildly raised, so this test helps support the picture rather than confirm it alone.
Electromyography and nerve studies can help show whether weakness is coming from muscle rather than nerve disease. These tests may feel uncomfortable, but they can help rule out other causes of similar symptoms.
How is Facioscapulohumeral muscular dystrophy 3 diagnosed?
Doctors usually diagnose facioscapulohumeral muscular dystrophy 3 by putting together the story of symptoms and the pattern of weakness on the exam, especially weakness in the face, shoulders, and upper arms, sometimes with blood tests, muscle scans, or tests that measure how well muscles and nerves are working to rule out other causes. Genetic testing is often used to confirm the diagnosis by looking for the gene change linked to this rare form of the condition. Because it can look like other muscle diseases, many people are diagnosed by a doctor who specializes in muscle or genetic conditions.
Stages of Facioscapulohumeral muscular dystrophy 3
Facioscapulohumeral muscular dystrophy 3 does not have defined progression stages. That is because symptoms usually vary from one person to another and tend to change gradually over time rather than moving through clear, set phases. Doctors usually start with a conversation about when weakness began, which muscles are affected, and whether there is a family history, then use a physical exam, blood tests, and sometimes muscle studies or genetic testing to confirm the diagnosis. Early symptoms of facioscapulohumeral muscular dystrophy 3 can be subtle, such as trouble lifting the arms to brush hair, a shoulder blade that sticks out, or a smile that seems less even in photos taken months apart.
Outlook and prognosis
The outlook for facioscapulohumeral muscular dystrophy 3 is often variable but generally compatible with a near-normal life span, especially in people with milder weakness. Symptoms usually progress slowly over many years, although the degree of muscle involvement, pain, fatigue, and functional limitation can differ widely even within the same family. Many affected individuals remain ambulatory for decades, but some eventually need assistive devices such as ankle-foot orthoses, canes, scooters, or wheelchairs. Life-threatening complications are uncommon, but severe respiratory weakness can occur in a minority of patients and may require monitoring and supportive care. Hearing loss, retinal vascular disease, and other extramuscular features are less common but can affect quality of life and warrant surveillance. Overall prognosis depends mainly on age at onset, severity and distribution of weakness, and whether complications develop, with supportive multidisciplinary care helping preserve mobility and independence.
Long-term effects
For many living with facioscapulohumeral muscular dystrophy 3, the long-term picture is often slow change over many years rather than a steady, rapid decline. Weakness usually affects the face, shoulders, and upper arms first, but its pace and severity can vary a lot from one person to another. Some people remain mildly affected for decades, while others develop more noticeable limits in daily movement and stamina.
Long-term weakness in facioscapulohumeral muscular dystrophy 3 often affects the face, shoulder muscles, and upper arms most clearly. Over time, this can make lifting objects, reaching overhead, whistling, or fully closing the eyes more difficult.
As shoulder weakness progresses, the shoulder blades may stick out and arm raising can become harder. For many, this can mean trouble putting dishes on a shelf, washing hair, or pulling on a shirt.
Some people with facioscapulohumeral muscular dystrophy 3 later develop weakness in the lower legs or hips, which can change the way they walk. Foot drop and reduced balance may make stairs, uneven ground, or long distances more tiring.
Ongoing muscle strain, joint stress, and altered posture can lead to chronic pain and tiredness. Even when weakness is mild, these day-to-day effects can shape work, exercise, and routine tasks.
How is it to live with Facioscapulohumeral muscular dystrophy 3?
Living with facioscapulohumeral muscular dystrophy 3 often means adapting to muscle weakness that usually affects the face, shoulders, upper arms, and sometimes the legs, and the day-to-day impact can vary widely from one person to another. For many people with FSHD3, this can mean trouble lifting the arms, carrying objects, climbing stairs, smiling fully, or keeping up with activities for long periods, so routines at school, work, and home may need pacing, physical therapy, and practical adjustments. The condition can also affect the people around you, because family, friends, and caregivers may take on more physical help or planning, but with support, mobility aids when needed, and an understanding circle, many living with FSHD3 build active, meaningful lives.
Treatment and drugs
Treatment for Facioscapulohumeral muscular dystrophy 3 focuses on managing symptoms, protecting muscle function, and helping people stay as active and independent as possible, because there is not yet a cure that stops the condition itself. Many living with Facioscapulohumeral muscular dystrophy 3 benefit from physical therapy, tailored exercise, stretching, and braces or other supports that can make walking, lifting the arms, or dealing with foot drop easier in daily life. Doctors may also treat related problems such as pain, poor sleep, breathing weakness, or eye issues, and in some cases surgery may help with specific concerns like shoulder stability. Treatment plans often combine several approaches. Since symptoms can vary a lot, the best treatment for Facioscapulohumeral muscular dystrophy 3 is usually personalized and may change over time.
Can you cure Facioscapulohumeral muscular dystrophy 3?
No, facioscapulohumeral muscular dystrophy 3 cannot be cured at this time. Treatment focuses on helping people stay active and independent for as long as possible by easing symptoms, supporting muscle strength and movement, managing pain, and using things like physical therapy, exercise plans, braces, or other mobility support when needed. Researchers are working on new treatments, but these are not yet a proven cure.
Non-drug treatment
Day-to-day life with facioscapulohumeral muscular dystrophy 3 often centers on managing shoulder, arm, facial, core, and leg weakness so everyday tasks stay safer and easier. Non-drug treatments often lay the foundation for staying mobile, protecting joints, and reducing fatigue, even though they do not cure the condition. Many living with facioscapulohumeral muscular dystrophy 3 do best with a mix of rehabilitation, practical equipment, and regular follow-up that is tailored to how mild or severe their symptoms are.
Physical therapy helps keep joints moving, supports posture, and can teach safer ways to walk, climb stairs, or lift the arms. A therapist usually focuses on gentle stretching, balance work, and low-to-moderate strengthening without pushing muscles to exhaustion. Not every approach works the same way, so physical therapy for facioscapulohumeral muscular dystrophy 3 is usually adjusted over time.
Regular, paced exercise can help many people maintain stamina, flexibility, and overall function. Low-impact activities such as walking, cycling, or swimming are often easier on weak muscles than high-resistance workouts. Too much strain can worsen fatigue, so programs should be individualized.
Occupational therapy helps with daily tasks like dressing, washing hair, typing, cooking, or reaching into cupboards when shoulder and arm weakness gets in the way. Some strategies can slip naturally into your routine—like changing how you set up a workspace or use kitchen tools. The goal is to save energy and protect independence.
Braces, shoe inserts, or ankle-foot orthoses can improve foot clearance, stability, and walking safety if foot drop or leg weakness develops. Shoulder supports may also help some people feel more comfortable during activity. These devices are chosen based on the pattern of weakness and how much support is needed.
Your genes may have an impact on how drugs work for you
For people living with facioscapulohumeral muscular dystrophy 3, treatment usually focuses on symptoms like pain, muscle stiffness, trouble sleeping, or low mood, and there is no well-established proof that the gene change behind this condition usually makes these common medicines work differently. That said, inherited differences from person to person can still affect how the body breaks down some medicines, so one person may get good relief while another feels little benefit or has more side effects, such as sleepiness or stomach upset. In day-to-day care, this is why doctors often start with low doses, watch closely, and adjust treatment to how each person responds.
Pharmacological treatments
Day-to-day treatment for facioscapulohumeral muscular dystrophy 3 usually focuses on easing symptoms such as pain, cramps, or poor sleep rather than slowing the muscle weakness itself. At this time, there is no approved medicine that clearly changes the course of facioscapulohumeral muscular dystrophy 3, so medications are chosen based on what is bothering someone most. Not everyone responds to the same medication in the same way.
There is currently no standard disease-modifying drug proven to stop or reverse facioscapulohumeral muscular dystrophy 3. Most prescriptions are used to manage symptoms and improve comfort, function, or sleep.
Acetaminophen may help mild to moderate muscle pain, especially after a more active day. It does not treat the underlying muscle disease, and taking too much can harm the liver.
Ibuprofen or naproxen may ease muscle and joint pain in some people with facioscapulohumeral muscular dystrophy 3. These drugs can irritate the stomach and may not be a good fit for people with kidney disease, ulcers, or blood thinner use.
If pain has a burning, tingling, or shooting quality, medicines such as gabapentin, pregabalin, or duloxetine may be considered. This can be part of treatment for muscle pain in facioscapulohumeral muscular dystrophy 3 when simple pain relievers are not enough.
Genetic influences
For many living with facioscapulohumeral muscular dystrophy 3, it can help to know why similar muscle weakness shows up in a family. This subtype is genetically defined: it is linked to a change in the LRIF1 gene, usually along with a particular chromosome 4 pattern that allows the DUX4 gene to stay active when it should be quiet. When that happens, muscle cells are gradually damaged, which leads to the familiar pattern of weakness in the face, shoulders, and upper arms. Even with the same gene change, people can have very different symptoms and ages when weakness begins. Because these genetic changes can be passed down, facioscapulohumeral muscular dystrophy 3 may affect several generations, although some relatives are much more mildly affected than others. Genetic testing for facioscapulohumeral muscular dystrophy 3 can help confirm the diagnosis and guide testing for close relatives.
Is Facioscapulohumeral muscular dystrophy 3 genetic?
Genetics are central to facioscapulohumeral muscular dystrophy 3. It is caused by changes affecting how the DUX4 gene is switched on, and these genetic differences can help confirm the diagnosis and explain why symptoms vary between families.
Having a genetic risk is not necessarily a diagnosis
Genetic variants are a normal feature of human biology and are widespread in the general population. Most of these variants do not directly affect health and are simply part of the natural differences seen among people. For many genes, having a variant connected to a condition suggests a possible link rather than a certain diagnosis, especially when several genes and environmental factors play a part. In some situations, though, a single well-characterized variant in a specific gene can be enough to confirm the diagnosis.
Pharmacogenetics—how genetics influence drug effects
Day to day, treatment for facioscapulohumeral muscular dystrophy 3 is still mostly about easing weakness, pain, fatigue, and movement problems, so the genetic result usually does not change routine care such as physical therapy, mobility aids, or common pain medicines. In facioscapulohumeral muscular dystrophy 3, the inherited change helps switch on harmful activity in muscle cells, and that matters most for confirming the diagnosis and guiding research-based treatment options. Not every difference in response is genetic, but doctors may use genetic testing for facioscapulohumeral muscular dystrophy 3 to tell it apart from other muscle disorders that can need different monitoring or different medicines. This can be important when symptoms look similar on the surface, such as shoulder weakness or trouble lifting the front of the foot, but the underlying cause is not the same. Right now, many living with facioscapulohumeral muscular dystrophy 3 do not have a gene-specific approved drug, so treatment remains supportive rather than targeted. As newer therapies are developed to block the harmful gene activity, the exact genetic finding will likely play a bigger role in choosing treatment and deciding who may benefit most.
Interactions with other conditions
For many living with facioscapulohumeral muscular dystrophy 3, the biggest day-to-day issue is not just muscle weakness itself, but how it can combine with other health problems and make walking, lifting, or even holding posture more tiring. Some may also have breathing muscle weakness or poor sleep from nighttime breathing problems, so lung disease, sleep apnea, or frequent chest infections can have a bigger effect than they would otherwise. Doctors call it a “comorbidity” when two conditions occur together, and in facioscapulohumeral muscular dystrophy 3 this can matter because pain, fatigue, hearing problems, or eye blood vessel changes may add to the burden in some people. If someone also has arthritis, back problems, or another nerve or muscle condition, it can be harder to sort out which issue is causing new weakness or discomfort. Mood conditions such as anxiety or depression may also become more noticeable when mobility changes over time, especially if daily tasks start taking more effort. Because early symptoms of facioscapulohumeral muscular dystrophy 3 can overlap with more common causes of shoulder or facial weakness, regular follow-up helps make sure other treatable conditions are not missed.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Facioscapulohumeral muscular dystrophy 3?
Other conditions that can look similar include the more common forms of facioscapulohumeral muscular dystrophy, other inherited muscle conditions such as limb-girdle muscular dystrophy, and muscle inflammation, often called myositis. Some nerve and nerve-to-muscle problems, including myasthenia gravis, which makes muscles tire and weaken easily, can also cause weakness in the face, shoulders, or upper arms and be mistaken for it. Doctors usually tell these apart by the exact pattern of weakness, family history, blood and muscle testing, and genetic testing.
History
People living with facioscapulohumeral muscular dystrophy 3 often notice changes that affect everyday tasks long before they ever hear the full medical name. It may start with trouble fully closing the eyes during sleep, difficulty lifting the arms to brush hair or reach a shelf, or shoulder blades that seem to stick out more than expected. Because these changes can appear gradually and vary so much from one family or person to another, the condition was not always easy for doctors to recognize in the past.
Facioscapulohumeral muscular dystrophy was first described in the medical literature in the late 1800s, when doctors began linking a distinct pattern of muscle weakness involving the face, shoulders, and upper arms. Early descriptions focused on what could be seen during an exam, such as weakness in facial muscles or the shoulder area, rather than on the deeper biological cause. Over time, doctors realized that this pattern belonged to a broader group of muscle diseases now called muscular dystrophies.
As medical science evolved, it became clear that facioscapulohumeral muscular dystrophy is not a single, identical experience for everyone. Some people have mild weakness for many years, while others develop symptoms earlier or have more noticeable effects on movement and daily life. This growing understanding helped doctors move away from older, narrower descriptions and recognize that several forms of the condition exist, including the less common type known as facioscapulohumeral muscular dystrophy 3.
In more recent years, laboratory research helped explain why the muscles are affected, and researchers later identified a genetic cause for this form of the condition. That progress changed diagnosis in a practical way: instead of relying only on symptoms and muscle exams, doctors could combine those findings with genetic testing for a clearer answer. Knowing this history helps explain why getting diagnosed with facioscapulohumeral muscular dystrophy 3 can still take time, especially when the early symptoms of facioscapulohumeral muscular dystrophy 3 are mild or mistaken for another muscle problem.